Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.
about
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Efficacy of and risk of bleedi ...... pretreatment thrombocytopenia.
@ast
Efficacy of and risk of bleedi ...... pretreatment thrombocytopenia.
@en
type
label
Efficacy of and risk of bleedi ...... pretreatment thrombocytopenia.
@ast
Efficacy of and risk of bleedi ...... pretreatment thrombocytopenia.
@en
prefLabel
Efficacy of and risk of bleedi ...... pretreatment thrombocytopenia.
@ast
Efficacy of and risk of bleedi ...... pretreatment thrombocytopenia.
@en
P2093
P2860
P50
P1476
Efficacy of and risk of bleedi ...... pretreatment thrombocytopenia
@en
P2093
A Torres-Cornejo
Grupo Andaluz para el Estudio ...... nfermedades Infecciosas (SAEI)
I de los Santos-Gil
M J Ríos-Villegas
M Pérez-Pérez
Red de Investigación en SIDA (RIS-HEP07)
P2860
P2888
P304
P356
10.1007/S10096-015-2426-6
P50
P577
2015-06-27T00:00:00Z
P6179
1010822831